EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria

Anupam Chakrapani iD, Jelena Stojanovic iD, Roshni Vara iD, Francesca De Nictolis iD, Marco Spada iD, Carlo Dionisi-Vici iD

Journal of Inherited Metabolic Disease · 2023-05 · 46 (3) · 466-481

DOI: 10.1002/jimd.12613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 24.04.2023. Verfasst von Anupam Chakrapani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Medicine, Great Ormond Street Hospital NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Liver Transplantation, Kidney Transplantation, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Propionic (PA) and methylmalonic aciduria (MMA) share many clinical similarities, which include the risk of acute metabolic encephalopathies, and some long‐term complications, such as optic neuropathy, pancreatic involvement, developmental disability, and similar management approaches, but they also represent distinct clinical and biochemical entities. In the severe forms of PA and MMA, most long‐term complications cannot be prevented with conventional clinical management. Organ transplantation represents a form of partial enzyme replacement to improve the long‐term outlook for these disorders. There is evidence that early liver transplant in both disorders greatly improves metabolic stability and reduces the risk of long‐term complications. For MMA, early liver transplant reduces methylmalonic acid levels which in turns reduces its effects on kidneys, and therefore slows progression of chronic kidney disease. However, established organ damage cannot be reversed. For patients with MMA who present with chronic kidney disease, consideration should be given for combined liver and kidney transplants. Transplantation in PA and MMA carries a high risk of complications and requires highly specialised pre‐operative and peri‐operative management. Involvement of a multidisciplinary team is essential and should include metabolic team, nephrologist, hepatologist, hepatobiliary and renal transplant surgeons, anaesthesiologists, cardiologists, intensive care team, dieticians and specialist nurses. These patients require life‐long multidisciplinary follow‐up. There is increasing evidence in the literature on excellent short to medium‐term patient and allograft survival following transplantation when patients are managed by a multidisciplinary team in a specialist centre. Improved early diagnosis and reductions in transplant‐related mortality and morbidity have allowed early transplantation to be used electively to further improve the outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acid Metabolism, Inborn ErrorsLiver TransplantationKidney TransplantationRenal Insufficiency, ChronicPropionic AcidemiaHumansMethylmalonic Acid

Stichwörter der Autor:innen

liver and kidney transplantationliver transplantationmethylmalonic aciduriapropionic aciduria

Substanzen

Methylmalonic Acid

Autor:innen und Institutionen

  • Department of Metabolic Medicine, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
  • University College Hospital, London, UK.
  • Department of Paediatric Nephrology and Transplantation, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Department of Paediatric Inherited Metabolic Diseases, Evelina London Children's Hospital, St Thomas' Hospital, London, UK.
  • Division of Metabolic Diseases, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Unit of Hepato-biliary-pancreatic Surgery, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.

ORCID-Profile: Anupam Chakrapani, Jelena Stojanovic, Roshni Vara, Francesca De Nictolis, Marco Spada, Carlo Dionisi-Vici

Zitieren

APA

Chakrapani, A., Stojanovic, J., Vara, R., De Nictolis, F., Spada, M., & Dionisi-Vici, C. (2023). Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria. Journal of Inherited Metabolic Disease, 46(3), 466-481. https://doi.org/10.1002/jimd.12613

Vancouver

Chakrapani A, Stojanovic J, Vara R, De Nictolis F, Spada M, Dionisi-Vici C. Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria. Journal of Inherited Metabolic Disease. 2023;46(3):466-481. doi:10.1002/jimd.12613

BibTeX
@article{Chakrapani2023,
  author = {Chakrapani, Anupam and Stojanovic, Jelena and Vara, Roshni and De Nictolis, Francesca and Spada, Marco and Dionisi-Vici, Carlo},
  title = {Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2023},
  volume = {46},
  number = {3},
  pages = {466--481},
  doi = {10.1002/jimd.12613}
}
Kostenlos starten →